跳至主要内容
临床试验/NCT00775762
NCT00775762Unknown3 期

Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events

Catholic University of the Sacred Heart1 个研究点 分布在 1 个国家目标入组 213 人开始时间: 2008年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
213
试验地点
1
主要终点
The aim of the present study is to demonstrate the superior antinflammatory effect of Clopidogrel and Aspirin vs Aspirin or Clopidogrel alone in term of levels of selected circulating inflammatory markers

研究概览

简要总结

This is a monocentric, randomized, opened study to assess the anti-inflammatory and anti-platelet effect of Clopidogrel and aspirin versus aspirin or clopidogrel alone in patients with symptomatic polyvascular disease and with multiple recurrent cardiovascular events.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with symptomatic polyvascular disease or recurrent cardiovascular events. In particular patients with established stable coronary artery disease associated with peripheral disease or cerebrovascular disease and patients with more than two acute cardiovascular events.

排除标准

  • chronic treatment with anticoagulant drugs and the use of other antiplatelet therapy;
  • intolerance/allergy to Aspirin or to Clopidogrel
  • platelet counts outside the range of 125-450 10^9/l
  • inflammatory or infectious disease
  • malignancies or immunologic or hematological disorders.

研究组 & 干预措施

aspirin

Active Comparator

干预措施: aspirin (Drug)

clopidogrel

Active Comparator

干预措施: clopidogrel (Drug)

clopidogrel plus aspirin

Active Comparator

干预措施: clopidogrel plus aspirin (Drug)

结局指标

主要结局

The aim of the present study is to demonstrate the superior antinflammatory effect of Clopidogrel and Aspirin vs Aspirin or Clopidogrel alone in term of levels of selected circulating inflammatory markers

时间窗: three months

次要结局

  • The aim of the present study is to demonstrate the superior antiplatelet effect of Clopidogrel and Aspirin vs Aspirin or Clopidogrel alone in term of TXA2 serum levels(three months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Anti-Inflammatory and Anti-Platelet Effect of... | 临床试验